Derivation and validation of adult Still Activity Score (SAS)

•Although Pouchot's systemic score is the most frequently used one, there is no universally accepted and used assessment tool for AOSD activity.•Still Activity Score (SAS): fever, arthralgia (+1 point if arthritis in≥2 joints), neutrophilia≥65% and ferritin≥350ng/mL.•Score is suitable for activ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Joint, bone, spine : revue du rhumatisme bone, spine : revue du rhumatisme, 2023-01, Vol.90 (1), p.105499-105499, Article 105499
Hauptverfasser: Kalyoncu, Umut, Kasifoglu, Timuçin, Omma, Ahmet, Bes, Cemal, Cinar, Muhammet, Emmungil, Hakan, Kucuksahin, Orhan, Akar, Servet, Aksu, Kenan, Yildiz, Fatih, Kanitez, Nilüfer Alpay, Erden, Abdulsamet, Bilgin, Emre, Dalkilic, Ediz, Ermurat, Selime, Hayran, Mutlu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Although Pouchot's systemic score is the most frequently used one, there is no universally accepted and used assessment tool for AOSD activity.•Still Activity Score (SAS): fever, arthralgia (+1 point if arthritis in≥2 joints), neutrophilia≥65% and ferritin≥350ng/mL.•Score is suitable for activity assessment of AOSD in clinical practice and clinical trials. Adult-onset Still's disease (AOSD) is a multi-systemic, autoinflammatory disorder. Several activity scores have been proposed but none of them have been adopted universally. Our aim was to create a clinician-friendly activity scoring system by using simple clinical and laboratory parameters. AODS patients, according to Yamaguchi criteria, were included in this cross-sectional, multicenter study. Derivation and validation cohorts were constituted. Demographic, clinical, and laboratory evaluation at the study visit; patients’ and physicians’ global assessments of disease activity (both VAS/Likert scale) were recorded. To develop the score, an ordinal logistic regression model was used to determine independent predictors of physicians’ global assessments of disease activity. Clinically and statistically significant variables were weighted according to regression coefficients. Then, performance of the score was tested on the validation cohort. A total of 197 consecutive AOSD patients (125 in derivation, 72 in validation cohorts) were included. Final Still Activity Score was fever (2 points), arthralgia (2 points, plus 1 point if arthritis was present in≥2 joints), neutrophilia≥65% (1 point) and ferritin≥350ng/mL (1 point) (maximum of 7 points). The SAS yielded an AUC value of 0.98 (0.96–1.00) in the derivation cohort and 0.91 (95%CI: 0.85–0.98) in the validation cohort to discriminate high AOSD activity from moderate-inactive AOSD. The correlation of SAS with PGA was 83% for the derivation cohort and 76% for the validation cohort. SAS has shown a good test performance to distinguish active AOSD patients from others. SAS may be a useful method for evaluating the disease activity of AOSD patients in daily practice.
ISSN:1297-319X
1778-7254
DOI:10.1016/j.jbspin.2022.105499